Sunshine Biopharma, Inc.
SBFM
$1.14
$0.032.70%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -1.56M | -1.24M | -2.14M | -883.80K | -1.77M |
| Total Depreciation and Amortization | 78.00K | 76.90K | 98.60K | 96.20K | 72.40K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 96.90K | -- | 142.00K | 554.70K | 1.06M |
| Change in Net Operating Assets | 471.20K | -905.10K | 284.30K | -494.80K | -636.80K |
| Cash from Operations | -918.00K | -2.07M | -1.62M | -727.80K | -1.27M |
| Capital Expenditure | -7.00K | -5.10K | 1.00K | -8.00K | -160.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -10.30K | 10.30K | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1.90K | -99.40K | -41.00K | -120.50K | -390.20K |
| Cash from Investing | -5.10K | -104.50K | -50.20K | -118.30K | -550.20K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | 75.50K | -- |
| Issuance of Common Stock | 7.80M | -- | 724.50K | 0.00 | 3.67M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 7.80M | -- | 724.50K | 75.50K | 3.67M |
| Foreign Exchange rate Adjustments | -45.80K | -33.70K | 758.60K | -228.30K | 335.70K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | 0.00 | -- |
| Net Change in Cash | 6.84M | -2.21M | -183.10K | -998.90K | 2.18M |